These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6491656)

  • 1. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
    Battaglia G; Shannon M; Titeler M
    J Neurochem; 1984 Nov; 43(5):1213-9. PubMed ID: 6491656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleotides modulate cortical S2 serotonin receptors.
    Titeler M; Battaglia G; Shannon M
    J Recept Res; 1984; 4(7):705-12. PubMed ID: 6527358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides.
    Lefkowitz RJ; Mullikin D; Caron MG
    J Biol Chem; 1976 Aug; 251(15):4686-92. PubMed ID: 947904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
    Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
    Battaglia G; Shannon M; Borgundvaag B; Titeler M
    Life Sci; 1983 Nov; 33(20):2011-6. PubMed ID: 6645787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanine nucleotide effects on agonist binding to serotonin 5HT2 receptors in rat frontal cortex.
    Shearman MS; Strange PG
    Biochem Pharmacol; 1988 Aug; 37(16):3097-102. PubMed ID: 3401241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA; Wolfe BB; Frazer A
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide and cation regulation of radioligand binding to Ri adenosine receptors of rat fat cells.
    Ukena D; Poeschla E; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):241-7. PubMed ID: 6089005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monovalent and divalent cations and of guanine nucleotides on binding of vasopressin to the rat mesenteric vasculature.
    Larivière R; Schiffrin EL
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1171-81. PubMed ID: 2957041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart muscarinic receptors: preferential detection at ambient temperature assay and location in two subcellular fractions.
    Sulakhe PV; Jagadeesh G; Phan NT; Rao TS; Veeranjaneyulu A
    Mol Cell Biochem; 1990 May; 94(2):133-46. PubMed ID: 2374547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
    De Keyser J; Dierckx R; Vanderheyden P; Ebinger G; Vauquelin G
    Brain Res; 1988 Mar; 443(1-2):77-84. PubMed ID: 2896059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.